Loading…

Disclaimer

Tidy Storm Portal (License No. 1611639) is for educational and informational purposes only. Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs.

You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Overview Tools X-Ray Watchlist

Biogen Inc Quality Score | GoodMoat

Biogen Inc (BIIB)

Biogen Inc — Quality Score

BIIB · NASDAQ · Healthcare

$182.31-1.61%

GoodMoat Target

$278.19Favourable+52.6% margin of safety

“At twenty times earnings, this biotech reminds me that in pharmaceuticals, yesterday's miracle drug often becomes tomorrow's patent cliff casualty.”

— In the voice of Munger

What is the Quality Score?

Evaluate financial health using Piotroski F-Score criteria — profitability, leverage, and operating efficiency metrics.

Key Metrics

Market Cap

$26.75B

P/E Ratio

20.69

Forward P/E

—

EPS

$8.83

PEG Ratio

-0.18

Book Value

$124.62

Dividend Yield

—

Profit Margin

13.07%

ROE

7.08%

Quality Score — Interactive Calculator

Free account • No credit card required

Use the interactive quality score with pre-loaded data for Biogen Inc. Adjust discount rates, growth assumptions, and projection horizons to model different scenarios.

Pre-loaded inputs for BIIB:

EPS: $8.83

P/E: 20.69

Book Value: $124.62

Shares Out: 0.15B

52-Week Range

$113.38

$201.18

More Tools for BIIB

DCF Calculator Fair Value Reverse DCF Company Overview Growth Projection Historical Performance

Company Info

SectorHealthcare

IndustryDrug Manufacturers - General

ExchangeNASDAQ